|
UQCC expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.195760E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.679300E-03 |
| Normal-vs-Stage2 |
2.552000E-01 |
| Normal-vs-Stage3 |
3.103200E-01 |
| Normal-vs-Stage4 |
4.287800E-01 |
| Stage1-vs-Stage2 |
9.161400E-01 |
| Stage1-vs-Stage3 |
9.967400E-01 |
| Stage1-vs-Stage4 |
8.040400E-01 |
| Stage2-vs-Stage3 |
9.467400E-01 |
| Stage2-vs-Stage4 |
8.747200E-01 |
| Stage3-vs-Stage4 |
8.649600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.194200E-04 |
| Normal-vs-AfricanAmerican |
4.207200E-01 |
| Normal-vs-Asian |
9.819400E-01 |
| Caucasian-vs-AfricanAmerican |
5.307900E-02 |
| Caucasian-vs-Asian |
4.604000E-01 |
| AfricanAmerican-vs-Asian |
7.662600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.191500E-04 |
| Normal-vs-Female |
4.020600E-01 |
| Male-vs-Female |
1.275780E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.164000E-01 |
| Normal-vs-Extreme_Weight |
9.169600E-02 |
| Normal-vs-Obese |
3.803600E-02 |
| Normal-vs-Extreme_Obese |
2.028800E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.509400E-01 |
| Normal_Weight-vs-Obese |
5.808400E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.757200E-01 |
| Extreme_Weight-vs-Obese |
6.539800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.932400E-01 |
| Obese-vs-Extreme_Obese |
6.443600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.595000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.808600E-04 |
| Normal-vs-Age(61-80Yrs) |
2.466400E-02 |
| Normal-vs-Age(81-100Yrs) |
1.283250E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.895800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.530000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.944800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.435770E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.059600E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.434300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.51799999999325E-05 |
| Normal-VS-Type2 PRCC |
5.534400E-01 |
| Normal-VS-KIRP CIMP |
4.24160000012108E-07 |
| Normal-VS-Unclassified PRCC |
1.457530E-02 |
| Type1 PRCC-VS-Type2 PRCC |
5.544200E-02 |
| Type1 PRCC-VS-KIRP CIMP |
3.11159999999422E-06 |
| Type1 PRCC-VS-Unclassified PRCC |
2.725000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.385400E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
4.692500E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.08569999999852E-05 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.247600E-01 |
| Normal-vs-N1 |
9.855400E-01 |
| Normal-vs-N2 |
1.916770E-01 |
| N0-vs-N1 |
5.152800E-01 |
| N0-vs-N2 |
2.508600E-01 |
| N1-vs-N2 |
2.677200E-01 |
|
|
